These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.
This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.
*Roberts, Richard. “Methods of Treating Ocular Disorders.” Kemin Industries, Inc., assignee.
Patent US9226940 B2. This patent covers three conditions for all ages; presbyopia, hyperopia, and astigmatism.
FloraGlo.com References available upon request from FloraGLO@Kemin.com.
ZeaONE® Zeaxanthin is distributed by DSM Nutritional Products as OPTISHARP® Natural in North America. U.S.A.
OPTISHARP® Natural is a registered trademark of DSM Nutritional Products.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
©2021 Kemin Industries, Inc. and its group of companies 2021 all rights reserved.